Does SOTROVIMAB Cause Hepatic cytolysis? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Hepatic cytolysis have been filed in association with SOTROVIMAB. This represents 0.3% of all adverse event reports for SOTROVIMAB.
11
Reports of Hepatic cytolysis with SOTROVIMAB
0.3%
of all SOTROVIMAB reports
0
Deaths
7
Hospitalizations
How Dangerous Is Hepatic cytolysis From SOTROVIMAB?
Of the 11 reports, 7 (63.6%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SOTROVIMAB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does SOTROVIMAB Cause?
Exposure during pregnancy (1,348)
Infusion related reaction (275)
Product storage error (259)
Off label use (231)
Pyrexia (185)
Covid-19 (158)
Nausea (135)
Dyspnoea (134)
Live birth (133)
Pruritus (107)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which SOTROVIMAB Alternatives Have Lower Hepatic cytolysis Risk?
SOTROVIMAB vs SOVALDI
SOTROVIMAB vs SOYBEAN OIL
SOTROVIMAB vs SPARSENTAN
SOTROVIMAB vs SPARTALIZUMAB
SOTROVIMAB vs SPESOLIMAB-SBZO